StayHappi Mefenamic Acid 250mg Tablet
Marketer
Sarvagunaushdhi Pvt Ltd
Salt Composition
Mefenamic Acid (250mg)
Overview StayHappi Mefenamic Acid 250mg Tablet
Alleviates moderate to severe pain, including menstrual cramps, headaches, muscle aches, joint pain, and toothaches, StayHappi Mefenamic Acid 250mg Tablets effectively manage both pain and inflammation. Administer this medication with food; dosage and treatment length vary depending on individual needs and symptom response. Continue the prescribed regimen until your physician advises otherwise, even if symptoms improve. Common, typically mild, side effects may include nausea, vomiting, stomach upset, headache, and dizziness. Report persistent or worsening side effects to your doctor, who can offer strategies for managing them. Prior to use, disclose any history of asthma, stomach ulcers, cardiovascular disease, hypertension, or liver/kidney impairment. Inform your doctor of all other medications you are currently using, as interactions are possible. Pregnant or breastfeeding individuals should seek medical advice before commencing treatment.
Uses of StayHappi Mefenamic Acid 250mg Tablet
Analgesia
Major Benefits of StayHappi Mefenamic Acid 250mg Tablet:
Consume StayHappi Mefenamic Acid 250mg tablets whole, with food, following your doctor's prescribed dosage and treatment schedule. Do not crush, chew, or divide the tablets.
Common Side effects of StayHappi Mefenamic Acid 250mg Tablet:
- Vomiting
- Stomach pain
- Nausea
- Headache
- Dizziness
How to use StayHappi Mefenamic Acid 250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the StayHappi Mefenamic Acid 250mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medicine with food.
How StayHappi Mefenamic Acid 250mg Tablet works:
StayHappi Mefenamic Acid 250mg tablets are non-steroidal anti-inflammatory drugs (NSAIDs) that inhibit the production of substances triggering fever, pain, and inflammatory responses like redness and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of StayHappi Mefenamic Acid 250mg Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Pregnant individuals should exercise caution when considering StayHappi Mefenamic Acid 250mg Tablets. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Medical advice is recommended.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can generally use StayHappi Mefenamic Acid 250mg Tablets without safety concerns. Research in humans indicates negligible transfer of the medication into breast milk, posing minimal risk to the infant.
DrivingUNSAFE
Using StayHappi Mefenamic Acid 250mg Tablets might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using StayHappi Mefenamic Acid 250mg Tablets, potentially requiring dosage modification under medical supervision. The use of StayHappi Mefenamic Acid 250mg Tablets is contraindicated in individuals with severely compromised kidney function. A physician's consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use StayHappi Mefenamic Acid 250mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take StayHappi Mefenamic Acid 250mg Tablet :
Should you forget a StayHappi Mefenamic Acid 250mg Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About StayHappi Mefenamic Acid 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Aminobenzoic Acid Derivative |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Action Class | Nonselective COX-1 and COX-2 inhibitors (e.g., fenamates) |
3,018 People bought this recently